BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3536506)

  • 21. In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis.
    Jones RB; Ridgway GL; Boulding S; Hunley KL
    Rev Infect Dis; 1983; 5 Suppl 3():S556-61. PubMed ID: 6635445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
    Miyashita N; Matsumoto A; Matsushima T
    Microbiol Immunol; 2000; 44(4):267-9. PubMed ID: 10832970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method.
    Cross NA; Kellock DJ; Kinghorn GR; Taraktchoglou M; Bataki E; Oxley KM; Hawkey PM; Eley A
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2311-3. PubMed ID: 10471587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An in-vitro investigation of synergy and antagonism between antimicrobials against Chlamydia trachomatis.
    How SJ; Hobson D; Hart CA; Webster RE
    J Antimicrob Chemother; 1985 May; 15(5):533-8. PubMed ID: 4008386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antimicrobial susceptibility of Chlamydia trachomatis in cell culture.
    Ridgway GL; Owen JM; Oriel JD
    Br J Vener Dis; 1978 Apr; 54(2):103-6. PubMed ID: 638716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
    Busolo F; Conventi L
    Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.
    Shang S; Xia L; Zhong M; Zhang J; Zhao J; Gong X; Mabey D; Wang Q
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1584-6. PubMed ID: 15793145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro sensitivity of Chlamydiae to antibiotics].
    Dailloux M; Ottemer C; Albert H; Weber M
    Pathol Biol (Paris); 1990 May; 38(5):426-30. PubMed ID: 2195451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
    Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
    Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of tetracyclines, macrolide antibiotics, and sigmamycin on staphylococci in vitro].
    Betinová M
    Biologia (Bratisl); 1968; 23(9):675-82. PubMed ID: 4971503
    [No Abstract]   [Full Text] [Related]  

  • 31. Activity of antimicrobials against Chlamydia trachomatis in vitro.
    Ridgway GL; Oriel JD
    J Antimicrob Chemother; 1979 Jul; 5(4):483-4. PubMed ID: 489497
    [No Abstract]   [Full Text] [Related]  

  • 32. Relative resistance to erythromycin in Chlamydia trachomatis.
    Mourad A; Sweet RL; Sugg N; Schachter J
    Antimicrob Agents Chemother; 1980 Nov; 18(5):696-8. PubMed ID: 7447426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.
    Lee CK; Bowie WR; Alexander ER
    Antimicrob Agents Chemother; 1978 Mar; 13(3):441-5. PubMed ID: 162541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlamydia trachomatis: in vitro susceptibility to antibiotics singly and in combination.
    Christensen JJ; Holten-Andersen W; Nielsen PB
    Acta Pathol Microbiol Immunol Scand B; 1986 Oct; 94(5):329-32. PubMed ID: 3788573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assaying antichlamydial drugs in vitro.
    Lycke E
    Scand J Infect Dis Suppl; 1982; 32():38-41. PubMed ID: 6958019
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
    DiPersio JR; Krafczyk TL
    Antimicrob Agents Chemother; 1978 Aug; 14(2):274-6. PubMed ID: 697353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the in vitro activity of various antibiotics against Chlamydia trachomatis by indirect immunoperoxidase method].
    Bannai H; Miyazawa H; Ashihara Y
    Kansenshogaku Zasshi; 1986 Oct; 60(10):1140-6. PubMed ID: 3100692
    [No Abstract]   [Full Text] [Related]  

  • 38. Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidis.
    Fuchs PC; Thornsberry C; Barry AL; Jones RN; Gavan TL; Gerlach EH; Sommers HM
    J Antibiot (Tokyo); 1979 Sep; 32(9):920-7. PubMed ID: 41833
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro activities of thirteen beta-lactam antibiotics against Chlamydia trachomatis.
    Muytjens HL; Heessen FW
    Antimicrob Agents Chemother; 1982 Sep; 22(3):520-1. PubMed ID: 7137988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
    Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
    Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.